Our COVID-19 measures remain in place. Feel safe at Sussex Premier Health hospitals. Read our Covid-19 Policy here
MBBS, MRCP (UK), MRCP (Dermatology)
General Medical Council Number: 7007302
I am a Dermatologist with a specialist expertise in medical dermatology (acne, eczema, psoriasis and other inflammatory skin conditions), skin cancer and surgery. In addition I have an interest in aesthetic dermatology.
I graduated from medical school in 2007 and I always wanted to be a Dermatologist. I did my training in Dermatology in Brighton and obtained my MRCP in Dermatology from the Royal Colleague of Physicians in 2018. I was appointed as a Consultant Dermatologist in Eastbourne in 2020.
Some of the principal treatments carried out by Dr Noor Alwash include:
Mole, cyst, wart and skin tag removal
Excessive sweating (hyperhidrosis)
Malignant skin cancer excision
Anti-wrinkle treatment by injection
Botox injection for wrinkles
Curettage and cautery
Fillers for cheeks and lips
Intra-lesional steroid injections for scars
MBBS / University of Jordan / 2007
Bachelor of Medicine, Bachelor of Surgery
British Association of Dermatologists
I have been involved in several research studies in dermatology including:
Heads UP study. A phase 3, randomized, multi-center study that will evaluate upadacitinib versus dupilumab in adults (18-75 years of age) with moderate to severe atopic dermatitis (AD) who are candidates for systemic therapy. The study is comprised of a 35-day screening period, a 24-week blinded treatment period, and a 12-week follow-up period.
ALLEGRO study. A global Phase 2b/3 study to evaluate the safety and effectiveness of an investigational study drug (called PF-06651600) in adults and adolescents (12 years and older) who have 50% or greater scalp hair loss
PROSE study (secukinumab in patients with severe chronic plaque psoriasis)
Secukinumab In patients with moderate to severe active, chronic plaque psoriasis who have failed on TNFa antaGoNists: A clinical Trial EvalUating Treatment REsults (SIGNATURE)
A Phase 3 Confirmatory Study Investigating the Efficacy and Safety of Dupilumab Monotherapy Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis.
Our first year experience in teledermatology. Presented as a poster presentation at the BAD annual meeting in July 2019. Abstract was published in the BJD.
A survey of the dermatological knowledge of tattoo artists. Presented as a poster at the BAD annual meeting in July 2019. Abstract was published in the BJD.
Extreme lip swelling caused by orofacial granuomatosis in two children and a novel and well tolerated treatment. Presented as a poster at the ESPD annual meeting in May 2019.
Consent forms for systemic and biologic therapy. Presented as a poster at the EADV annual meeting in 2018.
The Virtual Systemic Monitoring Clinic. Was presented as an oral presentation at the BAD annual meeting in July 2018. Abstract was published in the BJD.
A case of complete loss of all fingernails following application of gel nail polish. Presented as a poster at the BAD annual meeting in July 2018. Abstract was published in the BJD.
The use of the Therma probe biosensor in aiding the assessment and management of skin lesions. Presented as a poster at the BAD annual meeting in July 2018. Abstract was published in the BJD.
A case of unilateral rash in a 13 year old girl. Presented as a poster at the ESPD annual meeting in June 20
Consultant Dermatologist, East Sussex Healthcare NHS Trust
Private secretary: Penny Thomas
Private secretary telephone: 01273 627064
Private secretary email: firstname.lastname@example.org
Speak to a member of our team01424 757400 email@example.com